Exclusive: ACR Convergence 2024 | Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Conditions
FocusRheum
Guidance
Drug Updates
- Analgesics
- Biologics/DMARDs
Practice Support
- Billing/Coding
- EMRs
- Facility
- Insurance
- QA/QI
- Technology
- Workforce
Opinion
Career
ACR
Search

TNF Blockade for SLE

Martin Aringer, MD, and Maria Dall’Era, MD | Issue: September 2010 | September 1, 2010

Page: 1 2 3 4 5 6 7 | Single Page

Share:

Filed under:Conditions Systemic Lupus Erythematosus Tagged with:Lupus SLE Systemic lupus erythematosus TNF Blockade Treatment tumor necrosis factor

Related Articles

A&R Abstracts – HMGB1

August 1, 2011

For Further Reading

Top 12: Research in Systemic Lupus Erythematosus at a Glance

November 18, 2021

Dr. Pisetsky’s picks for the top research in lupus presented at ACR Convergence 2021.

Is B a Key to Autoimmune Therapy?: B Cell–targeted Therapies in Autoimmune Disease

January 1, 2010

A perspective on B cell–targeted therapies in autoimmune disease

T Cells in Systemic Lupus Erythematosus

August 1, 2011

Progress toward targeted therapy

About Us
Meet the Editors
Issue Archives
Contribute
Advertise
Contact Us

Copyright © 2000-2024 American College of Rheumatology. All rights reserved. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
DEI Statement
Privacy Policy
Terms of Use
Cookie Preferences